Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glioma-associated chlorotoxin-binding surface complex is a multi-protein assembly predominantly expressed on the plasma membrane of malignant glioma cells and other tumors of neuroectodermal origin (1.1.1, 1.2.2). This complex is characterized by the functional association of matrix metalloproteinase-2 (MMP-2), the chloride channel ClC-3, and annexin A2, often involving additional components like MT1-MMP and integrins (1.2.2, 1.2.4). Biologically, the complex facilitates the invasive phenotype of cancer cells by coordinating extracellular matrix degradation and the rapid cell volume changes required for migration through the brain parenchyma (1.2.2, 1.2.4). Chlorotoxin, a peptide derived from scorpion venom, serves as a highly specific ligand for this complex (1.1.1, 1.3.1). Binding of chlorotoxin or its derivatives leads to the sequestration and internalization of the complex via endocytosis, effectively inhibiting the enzymatic and transport activities that drive tumor progression (1.2.2, 1.2.4). This unique targeting mechanism has enabled the development of diagnostic tools like Tumor Paint (tozuleristide) for intraoperative visualization and therapeutic candidates like TM-601 for targeted radiotherapy (1.2.1, 1.2.4).
Chlorotoxin binds to the complex, specifically interacting with MMP-2 and ClC-3, which triggers the internalization of the entire complex through receptor-mediated endocytosis (1.2.2, 1.2.4). This process results in the downregulation of surface-expressed MMP-2 and chloride channels, thereby inhibiting the degradation of the extracellular matrix and the cell volume regulation necessary for tumor cell invasion and migration (1.2.2, 1.3.2). Additionally, chlorotoxin can serve as a delivery vehicle for cytotoxic isotopes or fluorescent dyes directly to the tumor site (1.2.1, 1.2.4).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glioma-associated chlorotoxin-binding surface complex.